Delivery Order SPE2DB20D1100-SPE2DB25FC7J7
Award Date
6/5/25
Potential Completion Date
6/6/25
Potential Value
$7.8K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a firm-fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $15,641.80 contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product, with a performance period ending on May 16, 2025. This delivery order is part of a larger $999,999,999.00 Indefinite Delivery Contract (IDC) held by Amerisourcebergen Drug Corp with the DLA Troop Support...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distribution company, for the supply of COSENTYX 300 MG DOSE-2 SYRINGE/ML. The contract has a firm fixed price of $6,087.84 and a completion date of August 9, 2023. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora, Inc., with the DLA Troop Support Medical that is valued at up to $999,999,999 and...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $11,391.53, is for the delivery of COSENTYX 300 MG DOSE-2 SYRINGEML, a pharmaceutical product, with a completion date of May 13, 2025. The contract is not set aside for any specific business category. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,937.52, is for the delivery of COSENTYX SNRDY 300MG DOSE-2PENML, a pharmaceutical product. The contract is a firm fixed-price delivery order with an ultimate completion date of April 21, 2025. This award is not associated with a set-aside program and appears to be part of a larger...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of COSENTYX 300 mg dose-2 syringes. The delivery order, valued at $4,565.85, was issued under an Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which has a not-to-exceed value of $999,999,999 and runs through December 2025. This IDC enables DLA to efficiently procure a wide range of pharmaceutical and medical supplies from AmerisourceBergen to...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract has a ceiling value of $10,049.70 and an ultimate completion date of December 18, 2024. It is a firm fixed-price contract for the delivery of COSENTYX 300 MG DOSE-2 SYRINGE ML, a specialty medication. The contract is not designated as a set-aside and is awarded...
This is a firm fixed-price delivery order issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,337.16 contract is for the supply of COSENTYX 300 MG DOSE-2 SYRINGE/ML, a medication used to treat certain medical conditions. The contract has an ultimate completion date of April 28, 2025. AmerisourceBergen holds a larger $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support...
This is a $12,526.21 Firm Fixed Price Delivery Order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML, a specialty pharmaceutical product. The delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026....
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $8,639.90, is for the supply of 4567705175 COSENTYX 300 MG DOSE-2 SYRINGE/ML, a specialty medication. The contract has an ultimate completion date of March 27, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC)...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $13,783.93 firm fixed-price contract is for the supply of COSENTYX SNRDY 300MG DOSE-2PENML medication. The contract has an ultimate completion date of May 19, 2025 and is not set aside. AmerisourceBergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop...